STAT Plus: Health-tech startups dream of partnering with big drug makers. First comes an intense winnowing process
A version of this story first appeared in STAT Health Tech, our weekly newsletter about how tech is transforming health care and the life sciences. Sign up here to receive it in your inbox.
For many ambitious health-tech startups, the holy grail is clear: landing a deal with a large biopharma company.
Continue to STAT Plus to read the full story…
